Activated Tryptophan-Kynurenine Metabolic System in the Human Brain is Associated with Learned Fear

Overview

Journal Front Mol Neurosci

Specialty Molecular Biology

Date 2023 Aug 14

PMID 37575966

Authors

Maria Rita Battaglia

Chiara Di Fazio

Simone Battaglia

Affiliations

Soon will be listed here.

Citing Articles

Therapeutic Metaphors Enhance Memory Systems in Mental Health Contexts.

Yu F, Zhang Z, Zhang W Brain Behav. 2025; 15(1):e70270.

PMID: 39829135 PMC: 11743976. DOI: 10.1002/brb3.70270.

Redefining Roles: A Paradigm Shift in Tryptophan-Kynurenine Metabolism for Innovative Clinical Applications.

Tanaka M, Szabo A, Vecsei L Int J Mol Sci. 2024; 25(23).

PMID: 39684480 PMC: 11640972. DOI: 10.3390/ijms252312767.

Compound 21 Attenuates Isoflurane-Induced Injury in Neonatal Rat Hippocampal Neurons and Primary Rat Neuronal Cells by Upregulating METTL3.

Shen Y, Wu Y, Zhuang H, Chen Z, Zhang Q, Li P J Inflamm Res. 2024; 17:10079-10091.

PMID: 39639929 PMC: 11618859. DOI: 10.2147/JIR.S483211.

Depression, stress, and tryptophan metabolism through the kynurenine pathway: treatment strategies from the perspective of Chinese herbal medicine.

Li W, Yang L, Chen H, Miao J, Wang Y, Zhou C Metab Brain Dis. 2024; 40(1):5.

PMID: 39546044 DOI: 10.1007/s11011-024-01461-1.

Neurocognitive Remediation Therapy: A Promising Approach to Enhance Cognition in Community Living Pilots with Depression and Anxiety.

Nuralieva N, Chang M, Huang L, Ts S Psychol Res Behav Manag. 2024; 17:2919-2939.

PMID: 39129790 PMC: 11314441. DOI: 10.2147/PRBM.S446634.

References

Di Gregorio F, La Porta F, Petrone V, Battaglia S, Orlandi S, Ippolito G . Accuracy of EEG Biomarkers in the Detection of Clinical Outcome in Disorders of Consciousness after Severe Acquired Brain Injury: Preliminary Results of a Pilot Study Using a Machine Learning Approach. Biomedicines. 2022; 10(8). PMC: 9405912. DOI: 10.3390/biomedicines10081897. View

Wonodi I, Stine O, Sathyasaikumar K, Roberts R, Mitchell B, Hong L . Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes. Arch Gen Psychiatry. 2011; 68(7):665-74. PMC: 3855543. DOI: 10.1001/archgenpsychiatry.2011.71. View

Tanaka M, Schally A, Telegdy G . Neurotransmission of the antidepressant-like effects of the growth hormone-releasing hormone antagonist MZ-4-71. Behav Brain Res. 2011; 228(2):388-91. DOI: 10.1016/j.bbr.2011.12.022. View

Nguyen N, Kimura A, Nakahama T, Chinen I, Masuda K, Nohara K . Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc Natl Acad Sci U S A. 2010; 107(46):19961-6. PMC: 2993339. DOI: 10.1073/pnas.1014465107. View

Buness A, Roth A, Herrmann A, Schmitz O, Kamp H, Busch K . Identification of metabolites, clinical chemistry markers and transcripts associated with hepatotoxicity. PLoS One. 2014; 9(5):e97249. PMC: 4023975. DOI: 10.1371/journal.pone.0097249. View

Fullana M, Harrison B, Soriano-Mas C, Vervliet B, Cardoner N, Avila-Parcet A . Neural signatures of human fear conditioning: an updated and extended meta-analysis of fMRI studies. Mol Psychiatry. 2015; 21(4):500-8. DOI: 10.1038/mp.2015.88. View

Bartoli F, Misiak B, Callovini T, Cavaleri D, Cioni R, Crocamo C . The kynurenine pathway in bipolar disorder: a meta-analysis on the peripheral blood levels of tryptophan and related metabolites. Mol Psychiatry. 2020; 26(7):3419-3429. DOI: 10.1038/s41380-020-00913-1. View

Capuron L, Neurauter G, Musselman D, Lawson D, Nemeroff C, Fuchs D . Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Biol Psychiatry. 2003; 54(9):906-14. DOI: 10.1016/s0006-3223(03)00173-2. View

Wu H, Guidetti P, Goodman J, Varasi M, Ceresoli-Borroni G, Speciale C . Kynurenergic manipulations influence excitatory synaptic function and excitotoxic vulnerability in the rat hippocampus in vivo. Neuroscience. 2000; 97(2):243-51. DOI: 10.1016/s0306-4522(00)00030-0. View

10.

Hirata Y, Kawachi T, Sugimura T . Fatty liver induced by injection of L-tryptophan. Biochim Biophys Acta. 1967; 144(2):233-41. View

11.

Hartley C, Fischl B, Phelps E . Brain structure correlates of individual differences in the acquisition and inhibition of conditioned fear. Cereb Cortex. 2011; 21(9):1954-62. PMC: 3155599. DOI: 10.1093/cercor/bhq253. View

12.

Sehlmeyer C, Schoning S, Zwitserlood P, Pfleiderer B, Kircher T, Arolt V . Human fear conditioning and extinction in neuroimaging: a systematic review. PLoS One. 2009; 4(6):e5865. PMC: 2692002. DOI: 10.1371/journal.pone.0005865. View

13.

Nilsson L, Nordin C, Jonsson E, Engberg G, Linderholm K, Erhardt S . Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors. J Psychiatr Res. 2006; 41(1-2):144-51. DOI: 10.1016/j.jpsychires.2005.12.001. View

14.

Erhardt S, Schwieler L, Imbeault S, Engberg G . The kynurenine pathway in schizophrenia and bipolar disorder. Neuropharmacology. 2016; 112(Pt B):297-306. DOI: 10.1016/j.neuropharm.2016.05.020. View

15.

Tanaka M, Diano M, Battaglia S . Editorial: Insights into structural and functional organization of the brain: evidence from neuroimaging and non-invasive brain stimulation techniques. Front Psychiatry. 2023; 14:1225755. PMC: 10291688. DOI: 10.3389/fpsyt.2023.1225755. View

16.

Erhardt S, Blennow K, Nordin C, Skogh E, Lindstrom L, Engberg G . Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia. Neurosci Lett. 2001; 313(1-2):96-8. DOI: 10.1016/s0304-3940(01)02242-x. View

17.

Iaccarino H, Suckow R, Xie S, Bucci D . The effect of transient increases in kynurenic acid and quinolinic acid levels early in life on behavior in adulthood: Implications for schizophrenia. Schizophr Res. 2013; 150(2-3):392-7. PMC: 3844520. DOI: 10.1016/j.schres.2013.09.004. View

18.

Marx W, McGuinness A, Rocks T, Ruusunen A, Cleminson J, Walker A . The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies. Mol Psychiatry. 2020; 26(8):4158-4178. DOI: 10.1038/s41380-020-00951-9. View

19.

Notarangelo F, Pocivavsek A . Elevated kynurenine pathway metabolism during neurodevelopment: Implications for brain and behavior. Neuropharmacology. 2016; 112(Pt B):275-285. PMC: 5010529. DOI: 10.1016/j.neuropharm.2016.03.001. View

20.

Perez-De la Cruz V, Konigsberg M, Santamaria A . Kynurenine pathway and disease: an overview. CNS Neurol Disord Drug Targets. 2008; 6(6):398-410. DOI: 10.2174/187152707783399229. View